Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.20
Delayed Data
As of 9:54am ET
 -0.02 / -0.90%
Today’s Change
2.19
Today|||52-Week Range
6.30
-39.23%
Year-to-Date

Today’s Trading

Previous close2.22
Today’s open2.20
Day’s range2.19 - 2.22
Volume2,834
Average volume (3 months)110,091
Market cap$53.4M
Dividend yield--
Data as of 9:54am ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+19.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-17.15%
P/E ratioNM
Price/Sales22.39
Price/Book21.44

Competitors

 Today’s
change
Today’s
% change
PLXPPLX Pharma Inc+0.15+2.25%
INFIInfinity Pharmaceuti...-0.01-0.90%
RNNRexahn Pharmaceutica...0.000.00%
GNMXAevi Genomic Medicin...-0.01-0.92%
Data as of 9:57am ET, 08/17/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$2.5M
Annual profit (last year)-$38.0M
Net profit margin-1,499.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Daniel N. Swisher
Chief Scientific Officer
Judith A. Fox
Corporate headquarters
South San Francisco, California

Forecasts